首页> 外文期刊>International Journal of Clinical and Experimental Medicine >Prognostic value of soluble cluster differentiationantigen 14 subtype and platelet activatingfactor in patients with septic shock
【24h】

Prognostic value of soluble cluster differentiationantigen 14 subtype and platelet activatingfactor in patients with septic shock

机译:可溶性簇分化抗原14亚型和血小板活化因子对脓毒性休克患者的预后价值

获取原文
           

摘要

Objective: The aim of this study was to observe and evaluate differential diagnosis and the prognosticvalue of serum soluble cluster differentiation antigen 14 subtype (sCD14-ST) and platelet activating factor (PAF)in septic shock. Methods: From February 2015 to February 2017, 15 patients with septic shock, 20 patients withsevere sepsis, and 30 patients with sepsis, in Jiaozhou People’s Hospital, were enrolled in this study. In the sameperiod, 30 healthy subjects were selected as the control group. Serum levels of sCD14-ST, PAF, procalcitonin (PCT),C reactive protein (CRP), and white blood cell count (WBC) were measured upon patient admission. Acute physiologyand chronic health status II (APACHE-II) scores were also calculated. Differences in each indicator amongthose groups were compared. Correlation between sCD14-ST, PAF, and APACHE-II scores was analyzed. Receiveroperating characteristic curve was used to compare values of various inflammatory markers in diagnosis of septicshock. Results: Levels of sCD14-ST, PAF, PCT, CRP, and WBC as well as scores of APACHE-II in patients with sepsis,severe sepsis, and septic shock were significantly higher than those in the healthy control group (all P0.05). Levelsof sCD14-ST and PAF in patients with septic shock were significantly higher than in patients with severe sepsisand sepsis (all P0.05). Levels of sCD14-ST and PAF in patients with septic shock were positively correlated withAPACHE-II scores. Multiple Logistic regression analysis showed that increase in APACHE-II scores, sCD14-ST, andPAF was an independent risk factor for death of patients with septic shock. Conclusion: sCD14-ST and PAF can beused as diagnostic indicators of septic shock and can monitor prognosis of sepsis.
机译:目的:本研究旨在观察和评估败血性休克中血清可溶性簇分化抗原14亚型(sCD14-ST)和血小板活化因子(PAF)的鉴别诊断和预后价值。方法:2015年2月至2017年2月,在胶州人民医院对15例败血性休克,20例严重脓毒症和30例脓毒症患者进行了研究。在同一时期,选择30名健康受试者作为对照组。患者入院时测定其血清sCD14-ST,PAF,降钙素原(PCT),C反应蛋白(CRP)和白细胞计数(WBC)。还计算了急性生理学和慢性健康状况II(APACHE-II)分数。比较了各组之间每个指标的差异。分析了sCD14-ST,PAF和APACHE-II评分之间的相关性。用增收特性曲线比较各种炎性标志物在败血性休克诊断中的价值。结果:脓毒症,严重脓毒症和脓毒性休克患者的sCD14-ST,PAF,PCT,CRP和WBC水平以及APACHE-II评分均显着高于健康对照组(均P <0.05) )。败血性休克患者的sCD14-ST和PAF水平明显高于重度脓毒症和脓毒症患者(均P <0.05)。败血性休克患者的sCD14-ST和PAF水平与APACHE-II得分呈正相关。多元Logistic回归分析表明,APACHE-II评分,sCD14-ST和PAF升高是败血性休克患者死亡的独立危险因素。结论:sCD14-ST和PAF可作为败血性休克的诊断指标,并可监测败血症的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号